首页 > 最新文献

Neurosurgery最新文献

英文 中文
Next-Generation Neuromonitoring in Minimally Invasive Spine Surgery: Indications, Techniques, and Clinical Outcomes.
IF 3.9 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-03-01 Epub Date: 2025-02-14 DOI: 10.1227/neu.0000000000003330
Chibuikem A Ikwuegbuenyi, Noah Willett, Galal Elsayed, Osama Kashlan, Roger Härtl

Neuromonitoring in minimally invasive spine surgery (MISS) provides real-time feedback to surgeons and enhances surgical precision for improved patient safety. Since the 1970s, established techniques like somatosensory evoked potentials, motor evoked potentials, and electromyography have been integrated into spine surgeries, significantly reducing the risk of neurological complications. These neuromonitoring modalities have been crucial, particularly in complex procedures with limited direct visualization. Refinements in these techniques have led to greater confidence in nerve root safety, contributing to the success of MISS. Despite some debate regarding the routine use of neuromonitoring in noncomplex surgeries, its importance in complex cases is well-documented. Studies have demonstrated high sensitivity and specificity rates for these techniques, with multimodal approaches offering the best outcomes. Advancements in mechanomyography and its potential integration into neuromonitoring protocols highlight the continuous improvement in this field. This review explores the historical development, current techniques, clinical outcomes, and future directions of neuromonitoring in MISS. It emphasizes the critical role of these technologies in enhancing surgical outcomes and patient care. As MISS continues to evolve, adopting next-generation neuromonitoring systems, including artificial intelligence and machine learning, will play a pivotal role in advancing the efficacy and safety of spine surgeries.

{"title":"Next-Generation Neuromonitoring in Minimally Invasive Spine Surgery: Indications, Techniques, and Clinical Outcomes.","authors":"Chibuikem A Ikwuegbuenyi, Noah Willett, Galal Elsayed, Osama Kashlan, Roger Härtl","doi":"10.1227/neu.0000000000003330","DOIUrl":"https://doi.org/10.1227/neu.0000000000003330","url":null,"abstract":"<p><p>Neuromonitoring in minimally invasive spine surgery (MISS) provides real-time feedback to surgeons and enhances surgical precision for improved patient safety. Since the 1970s, established techniques like somatosensory evoked potentials, motor evoked potentials, and electromyography have been integrated into spine surgeries, significantly reducing the risk of neurological complications. These neuromonitoring modalities have been crucial, particularly in complex procedures with limited direct visualization. Refinements in these techniques have led to greater confidence in nerve root safety, contributing to the success of MISS. Despite some debate regarding the routine use of neuromonitoring in noncomplex surgeries, its importance in complex cases is well-documented. Studies have demonstrated high sensitivity and specificity rates for these techniques, with multimodal approaches offering the best outcomes. Advancements in mechanomyography and its potential integration into neuromonitoring protocols highlight the continuous improvement in this field. This review explores the historical development, current techniques, clinical outcomes, and future directions of neuromonitoring in MISS. It emphasizes the critical role of these technologies in enhancing surgical outcomes and patient care. As MISS continues to evolve, adopting next-generation neuromonitoring systems, including artificial intelligence and machine learning, will play a pivotal role in advancing the efficacy and safety of spine surgeries.</p>","PeriodicalId":19276,"journal":{"name":"Neurosurgery","volume":"96 3S","pages":"S111-S118"},"PeriodicalIF":3.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143414446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Augmented Reality in Spine Surgery.
IF 3.9 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-03-01 Epub Date: 2025-02-14 DOI: 10.1227/neu.0000000000003343
Bayard R Wilson, Timothy Y Wang, John O'Toole

Augmented reality (AR) is a technology that allows digital information to be superimposed onto a user's view of the real world, thereby enhancing the user's experience of a given real-world scenario. As recent advances in AR technology have made it more available for a variety of applications, hospitals and doctors have begun to test its utility in the operating room. AR technology allows surgeons to supplement their view of the operative field with useful patient-specific information for which they might otherwise need to turn their attention away from the task at hand. For spine surgeons in particular, AR has begun to emerge as a promising option to assist with surgical performance. The field of spine surgery is uniquely positioned to benefit from AR, given the extent to which many spine surgeons already rely on intraoperative navigation techniques for certain surgical tasks, including pedicle screw and interbody device placement. In this review, we outline the origins and history of AR in spine surgery and cover the current state of the literature regarding the applications, benefits, and drawbacks of its use within the field. Lastly, we speculate as to the future of AR in spine surgery and propose which gaps in knowledge must be addressed before the technology enjoys a degree of adoption on par with currently available intraoperative navigation techniques.

{"title":"Augmented Reality in Spine Surgery.","authors":"Bayard R Wilson, Timothy Y Wang, John O'Toole","doi":"10.1227/neu.0000000000003343","DOIUrl":"https://doi.org/10.1227/neu.0000000000003343","url":null,"abstract":"<p><p>Augmented reality (AR) is a technology that allows digital information to be superimposed onto a user's view of the real world, thereby enhancing the user's experience of a given real-world scenario. As recent advances in AR technology have made it more available for a variety of applications, hospitals and doctors have begun to test its utility in the operating room. AR technology allows surgeons to supplement their view of the operative field with useful patient-specific information for which they might otherwise need to turn their attention away from the task at hand. For spine surgeons in particular, AR has begun to emerge as a promising option to assist with surgical performance. The field of spine surgery is uniquely positioned to benefit from AR, given the extent to which many spine surgeons already rely on intraoperative navigation techniques for certain surgical tasks, including pedicle screw and interbody device placement. In this review, we outline the origins and history of AR in spine surgery and cover the current state of the literature regarding the applications, benefits, and drawbacks of its use within the field. Lastly, we speculate as to the future of AR in spine surgery and propose which gaps in knowledge must be addressed before the technology enjoys a degree of adoption on par with currently available intraoperative navigation techniques.</p>","PeriodicalId":19276,"journal":{"name":"Neurosurgery","volume":"96 3S","pages":"S103-S110"},"PeriodicalIF":3.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143414847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gene Expression Changes Associated With Recurrence After Gross Total Resection of Newly Diagnosed World Health Organization Grade 1 Meningioma. 与新确诊的世界卫生组织 1 级脑膜瘤全切除术后复发有关的基因表达变化
IF 3.9 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-03-01 Epub Date: 2024-08-05 DOI: 10.1227/neu.0000000000003133
Ramin A Morshed, Minh P Nguyen, Mark W Youngblood, Haley K Perlow, Calixto-Hope G Lucas, Akash J Patel, Joshua D Palmer, James P Chandler, Philip V Theodosopoulos, Stephen T Magill, William C Chen, David R Raleigh

Background and objective: Patients who undergo gross total resection (GTR) of Central Nervous System World Health Organization (WHO) grade 1 meningioma constitute a "low-risk" group, but some low-risk meningiomas can recur despite reassuring clinical and histological features. In this study, gene expression values in newly diagnosed WHO grade 1 meningiomas that had undergone GTR were evaluated for their association with recurrence.

Methods: This was a retrospective, international, multicenter cohort study that included WHO grade 1 meningiomas that underwent GTR, as first treatment, based on postoperative magnetic resonance imaging. Normalized gene expression values from a previously validated 34-gene panel were evaluated for their association with recurrence. Kaplan-Meier, multivariable Cox proportional hazard analyses, and K-means clustering were performed to assess the association of genes of interest with recurrence and identify molecular subgroups among clinically and histologically low-risk meningiomas.

Results: In total, 442 patients with WHO grade 1 meningiomas that underwent GTR and had available gene expression profiling data were included in the study. The median follow-up was 5.0 years (interquartile range 2.6-7.7 years), local recurrence occurred in 36 patients (8.1%), 5-year local freedom from recurrence was 90.5%, and median time to recurrence was 2.9 years (range 0.5-10.7 years). Eleven genes were associated with local recurrence, including lower expression of ARID1B , ESR1 , LINC02593 , PGR , and TMEM30B and higher expression of CDK6 , CDKN2C , CKS2 , KIF20A , PGK1 , and TAGLN . Of these genes, PGK1 had the largest effect size. K-means clustering based on these 11 genes distinguished 2 molecular groups of clinically and histologically low-risk meningiomas with significant differences in local freedom from recurrence (hazard ratio 2.5, 95% CI 1.2-5.1, P = .016).

Conclusion: Gene expression profiling may help to identify newly diagnosed WHO grade 1 meningiomas that have an elevated risk of recurrence despite GTR.

背景和目的:接受世界卫生组织(WHO)中枢神经系统1级脑膜瘤全切除术(GTR)的患者属于 "低风险 "群体,但尽管临床和组织学特征令人放心,一些低风险脑膜瘤仍会复发。本研究评估了新诊断的WHO 1级脑膜瘤的基因表达值与复发的关系:这是一项回顾性、国际性、多中心队列研究,研究对象包括根据术后磁共振成像结果首次接受GTR治疗的WHO 1级脑膜瘤。研究人员评估了先前验证的 34 个基因面板的归一化基因表达值与复发的关系。通过Kaplan-Meier、多变量Cox比例危险分析和K-means聚类分析,评估了相关基因与复发的关系,并确定了临床和组织学上低风险脑膜瘤的分子亚组:研究共纳入了442例接受过GTR且有基因表达谱数据的WHO 1级脑膜瘤患者。中位随访时间为5.0年(四分位数间距为2.6-7.7年),36例患者(8.1%)出现局部复发,5年局部无复发率为90.5%,中位复发时间为2.9年(0.5-10.7年)。11个基因与局部复发相关,包括ARID1B、ESR1、LINC02593、PGR和TMEM30B的较低表达,CDK6、CDKN2C、CKS2、KIF20A、PGK1和TAGLN的较高表达。在这些基因中,PGK1 的效应大小最大。基于这11个基因的K-均值聚类将临床和组织学上低风险的脑膜瘤区分为2个分子组,这2个分子组在局部无复发方面存在显著差异(危险比2.5,95% CI 1.2-5.1,P = .016):基因表达谱分析可能有助于鉴别新诊断的WHO 1级脑膜瘤,这些脑膜瘤尽管有GTR,但复发风险较高。
{"title":"Gene Expression Changes Associated With Recurrence After Gross Total Resection of Newly Diagnosed World Health Organization Grade 1 Meningioma.","authors":"Ramin A Morshed, Minh P Nguyen, Mark W Youngblood, Haley K Perlow, Calixto-Hope G Lucas, Akash J Patel, Joshua D Palmer, James P Chandler, Philip V Theodosopoulos, Stephen T Magill, William C Chen, David R Raleigh","doi":"10.1227/neu.0000000000003133","DOIUrl":"10.1227/neu.0000000000003133","url":null,"abstract":"<p><strong>Background and objective: </strong>Patients who undergo gross total resection (GTR) of Central Nervous System World Health Organization (WHO) grade 1 meningioma constitute a \"low-risk\" group, but some low-risk meningiomas can recur despite reassuring clinical and histological features. In this study, gene expression values in newly diagnosed WHO grade 1 meningiomas that had undergone GTR were evaluated for their association with recurrence.</p><p><strong>Methods: </strong>This was a retrospective, international, multicenter cohort study that included WHO grade 1 meningiomas that underwent GTR, as first treatment, based on postoperative magnetic resonance imaging. Normalized gene expression values from a previously validated 34-gene panel were evaluated for their association with recurrence. Kaplan-Meier, multivariable Cox proportional hazard analyses, and K-means clustering were performed to assess the association of genes of interest with recurrence and identify molecular subgroups among clinically and histologically low-risk meningiomas.</p><p><strong>Results: </strong>In total, 442 patients with WHO grade 1 meningiomas that underwent GTR and had available gene expression profiling data were included in the study. The median follow-up was 5.0 years (interquartile range 2.6-7.7 years), local recurrence occurred in 36 patients (8.1%), 5-year local freedom from recurrence was 90.5%, and median time to recurrence was 2.9 years (range 0.5-10.7 years). Eleven genes were associated with local recurrence, including lower expression of ARID1B , ESR1 , LINC02593 , PGR , and TMEM30B and higher expression of CDK6 , CDKN2C , CKS2 , KIF20A , PGK1 , and TAGLN . Of these genes, PGK1 had the largest effect size. K-means clustering based on these 11 genes distinguished 2 molecular groups of clinically and histologically low-risk meningiomas with significant differences in local freedom from recurrence (hazard ratio 2.5, 95% CI 1.2-5.1, P = .016).</p><p><strong>Conclusion: </strong>Gene expression profiling may help to identify newly diagnosed WHO grade 1 meningiomas that have an elevated risk of recurrence despite GTR.</p>","PeriodicalId":19276,"journal":{"name":"Neurosurgery","volume":" ","pages":"521-528"},"PeriodicalIF":3.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141889858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reconstructive Endovascular Treatment of Compensative-Flow-Related Posterior Circulation Aneurysms With Anterior Circulation Artery Occlusion. 对伴有前循环动脉闭塞的补偿性血流相关后循环动脉瘤进行血管内重建治疗。
IF 3.9 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-03-01 Epub Date: 2024-08-21 DOI: 10.1227/neu.0000000000003148
Tao Quan, Xin Zhang, Jinyi Li, Zhaofei Wang, Xiaojie Fu, Xin Feng, Haowen Xu, Chuanzhi Duan, Sheng Guan

Background and objectives: The aim of this study was to delineate the reconstructive endovascular treatment and periprocedural management of compensative-flow-related posterior circulation aneurysms with anterior circulation artery occlusion.

Methods: A total of 87 patients were enrolled in this retrospective double-center cohort study from May 2011 to November 2023. The baseline demographics, aneurysm characteristics, etiology and status of anterior circulation artery occlusion, treatment modalities, anesthesia management, complications, and clinical and angiographic outcomes of the patients were retrospectively analyzed in this study.

Results: Atherosclerosis and moyamoya disease were found to be the two main etiologies of anterior circulation artery occlusion. The mean American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology scores were significantly higher in patients with posterior communicating artery trunk collaterals than those with posterior cerebral artery pial collaterals ( P < .05). Treatment strategies included stent-assisted coiling (55, 63.2%), standard coiling (22, 25.3%), and flow diversion or flow diversion-assisted coiling (8, 9.2%). The overall rate of procedure-related ischemic and hemorrhagic complications (10.3%) was considered acceptable. The ischemic complication was significantly associated with a >20% drop in mean arterial pressure ( P < .05) during the procedure. Finally, 86.2% of all patients showed a modified Rankin Scale score of 0 to 2 at the final clinical follow-up.

Conclusion: Our study indicates that reconstructive endovascular treatments are feasible and effective strategies for compensative-flow-related posterior circulation aneurysms with anterior circulation artery occlusion. However, these treatments are associated with a risk of periprocedural ischemic complications, which can be reduced by collateral arterial assessment, appropriate periprocedural anesthesia management, and antiplatelet treatment.

背景和目的:本研究旨在探讨代偿性血流相关后循环动脉瘤伴前循环动脉闭塞的重建性血管内治疗和围手术期管理:2011年5月至2023年11月期间,共有87名患者参与了这项回顾性双中心队列研究。本研究对患者的基线人口统计学、动脉瘤特征、病因和前循环动脉闭塞状况、治疗方式、麻醉管理、并发症以及临床和血管造影结果进行了回顾性分析:结果:动脉粥样硬化和莫亚莫亚病是前循环动脉闭塞的两种主要病因。美国介入和治疗神经放射学会/介入放射学会对后交通动脉主干袢患者的平均评分明显高于大脑后动脉皮质袢患者(P < .05)。治疗策略包括支架辅助卷扎术(55,63.2%)、标准卷扎术(22,25.3%)以及血流分流或血流分流辅助卷扎术(8,9.2%)。与手术相关的缺血性和出血性并发症总发生率(10.3%)被认为是可以接受的。缺血性并发症与术中平均动脉压下降>20%(P < .05)有显著相关性。最后,86.2%的患者在最后的临床随访中显示改良Rankin量表评分为0至2分:我们的研究表明,对于代偿性血流相关后循环动脉瘤伴前循环动脉闭塞,重建血管内治疗是可行且有效的策略。然而,这些治疗方法与围手术期缺血性并发症的风险相关,通过侧支动脉评估、适当的围手术期麻醉管理和抗血小板治疗,可以降低这种风险。
{"title":"Reconstructive Endovascular Treatment of Compensative-Flow-Related Posterior Circulation Aneurysms With Anterior Circulation Artery Occlusion.","authors":"Tao Quan, Xin Zhang, Jinyi Li, Zhaofei Wang, Xiaojie Fu, Xin Feng, Haowen Xu, Chuanzhi Duan, Sheng Guan","doi":"10.1227/neu.0000000000003148","DOIUrl":"10.1227/neu.0000000000003148","url":null,"abstract":"<p><strong>Background and objectives: </strong>The aim of this study was to delineate the reconstructive endovascular treatment and periprocedural management of compensative-flow-related posterior circulation aneurysms with anterior circulation artery occlusion.</p><p><strong>Methods: </strong>A total of 87 patients were enrolled in this retrospective double-center cohort study from May 2011 to November 2023. The baseline demographics, aneurysm characteristics, etiology and status of anterior circulation artery occlusion, treatment modalities, anesthesia management, complications, and clinical and angiographic outcomes of the patients were retrospectively analyzed in this study.</p><p><strong>Results: </strong>Atherosclerosis and moyamoya disease were found to be the two main etiologies of anterior circulation artery occlusion. The mean American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology scores were significantly higher in patients with posterior communicating artery trunk collaterals than those with posterior cerebral artery pial collaterals ( P < .05). Treatment strategies included stent-assisted coiling (55, 63.2%), standard coiling (22, 25.3%), and flow diversion or flow diversion-assisted coiling (8, 9.2%). The overall rate of procedure-related ischemic and hemorrhagic complications (10.3%) was considered acceptable. The ischemic complication was significantly associated with a >20% drop in mean arterial pressure ( P < .05) during the procedure. Finally, 86.2% of all patients showed a modified Rankin Scale score of 0 to 2 at the final clinical follow-up.</p><p><strong>Conclusion: </strong>Our study indicates that reconstructive endovascular treatments are feasible and effective strategies for compensative-flow-related posterior circulation aneurysms with anterior circulation artery occlusion. However, these treatments are associated with a risk of periprocedural ischemic complications, which can be reduced by collateral arterial assessment, appropriate periprocedural anesthesia management, and antiplatelet treatment.</p>","PeriodicalId":19276,"journal":{"name":"Neurosurgery","volume":" ","pages":"630-639"},"PeriodicalIF":3.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142018134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Reply: Working Status in Patients With Untreated Unruptured Intracranial Aneurysms: A Descriptive Longitudinal Study. 回复中:未经治疗的未破裂颅内动脉瘤患者的工作状态:描述性纵向研究。
IF 3.9 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-03-01 Epub Date: 2024-12-20 DOI: 10.1227/neu.0000000000003316
Paulina Majewska, Ole Solheim
{"title":"In Reply: Working Status in Patients With Untreated Unruptured Intracranial Aneurysms: A Descriptive Longitudinal Study.","authors":"Paulina Majewska, Ole Solheim","doi":"10.1227/neu.0000000000003316","DOIUrl":"10.1227/neu.0000000000003316","url":null,"abstract":"","PeriodicalId":19276,"journal":{"name":"Neurosurgery","volume":" ","pages":"e73-e74"},"PeriodicalIF":3.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142865008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter: What Are We Transfusing? Evaluating the Quality and Clinical Utility of Intraoperatively Salvaged Red Blood Cells in Spinal Deformity Surgery: A Nonrandomized Controlled Trial. 信:我们在输什么?评估脊柱畸形手术中术中回收红细胞的质量和临床应用:一项非随机对照试验。
IF 3.9 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-03-01 Epub Date: 2025-01-08 DOI: 10.1227/neu.0000000000003322
Serhat Aydin, Abigail Jenkins, Donald Detchou, Mert Karabacak, Umaru Barrie, Salah G Aoun
{"title":"Letter: What Are We Transfusing? Evaluating the Quality and Clinical Utility of Intraoperatively Salvaged Red Blood Cells in Spinal Deformity Surgery: A Nonrandomized Controlled Trial.","authors":"Serhat Aydin, Abigail Jenkins, Donald Detchou, Mert Karabacak, Umaru Barrie, Salah G Aoun","doi":"10.1227/neu.0000000000003322","DOIUrl":"10.1227/neu.0000000000003322","url":null,"abstract":"","PeriodicalId":19276,"journal":{"name":"Neurosurgery","volume":" ","pages":"e68-e69"},"PeriodicalIF":3.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142952121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evolution of the Minimally Invasive Surgery Transforaminal Lumbar Interbody Fusion: Where Are We Now?
IF 3.9 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-03-01 Epub Date: 2025-02-14 DOI: 10.1227/neu.0000000000003336
Abraham Dada, Satvir Saggi, Vardhaan S Ambati, Arati Patel, Praveen V Mummaneni

The transforaminal lumbar interbody fusion (TLIF) technique, pioneered by Harms and Rolinger in 1982 and further refined in the early 2000s by Rosenberg and Mummaneni and later by Foley and Lefkowitz, uses Kambin triangle to access the disc space, thecal sac, and nerve roots. The minimally invasive surgery (MIS) approach to TLIF minimizes soft tissue disruption and spinal segment destabilization, offering benefits such as reduced operative times, blood loss, complications, and postoperative opiate use, with comparable fusion rates to open techniques. Despite these advantages, MIS interbody selection poses challenges, with the MIS TLIF preferred for L4-5 fusions when lordosis restoration is not needed. Key to the MIS TLIF technique is the use of expandable retractors, image-guided pedicle screw placement, and innovations like the expandable TLIF, which improves disc space lordosis. Navigation technologies, including 3-dimensional navigation, augmented reality, and robotics, may enhance surgical accuracy and visualization and may allow more precise screw and cage placement and reducing operative time and complications. Awake MIS TLIF, incorporating conscious sedation and local anesthesia, offers additional benefits of faster discharge and reduced postoperative pain. Some authors have also started using endoscopic techniques as well to further minimize tissue trauma. The integration of these advanced techniques and technologies in MIS TLIF continues to improve surgical outcomes and expands the applicability of this minimally invasive approach, making it a valuable tool in spine surgery.

{"title":"Evolution of the Minimally Invasive Surgery Transforaminal Lumbar Interbody Fusion: Where Are We Now?","authors":"Abraham Dada, Satvir Saggi, Vardhaan S Ambati, Arati Patel, Praveen V Mummaneni","doi":"10.1227/neu.0000000000003336","DOIUrl":"https://doi.org/10.1227/neu.0000000000003336","url":null,"abstract":"<p><p>The transforaminal lumbar interbody fusion (TLIF) technique, pioneered by Harms and Rolinger in 1982 and further refined in the early 2000s by Rosenberg and Mummaneni and later by Foley and Lefkowitz, uses Kambin triangle to access the disc space, thecal sac, and nerve roots. The minimally invasive surgery (MIS) approach to TLIF minimizes soft tissue disruption and spinal segment destabilization, offering benefits such as reduced operative times, blood loss, complications, and postoperative opiate use, with comparable fusion rates to open techniques. Despite these advantages, MIS interbody selection poses challenges, with the MIS TLIF preferred for L4-5 fusions when lordosis restoration is not needed. Key to the MIS TLIF technique is the use of expandable retractors, image-guided pedicle screw placement, and innovations like the expandable TLIF, which improves disc space lordosis. Navigation technologies, including 3-dimensional navigation, augmented reality, and robotics, may enhance surgical accuracy and visualization and may allow more precise screw and cage placement and reducing operative time and complications. Awake MIS TLIF, incorporating conscious sedation and local anesthesia, offers additional benefits of faster discharge and reduced postoperative pain. Some authors have also started using endoscopic techniques as well to further minimize tissue trauma. The integration of these advanced techniques and technologies in MIS TLIF continues to improve surgical outcomes and expands the applicability of this minimally invasive approach, making it a valuable tool in spine surgery.</p>","PeriodicalId":19276,"journal":{"name":"Neurosurgery","volume":"96 3S","pages":"S33-S41"},"PeriodicalIF":3.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143414103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biportal Versus Uniportal Lumbar Decompression-Indications and Efficacy: A Review With Case Examples.
IF 3.9 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-03-01 Epub Date: 2025-02-14 DOI: 10.1227/neu.0000000000003339
Felicia W Sun, Ki-Eun Chang, Jian Shen, Albert E Telfeian

Minimally invasive lumbar decompression surgery offers many advantages including reduced patient morbidity and quicker return to normal life. Endoscopic lumbar spine surgery, sometimes termed "ultra" minimally invasive, further pushes the envelope on reducing operative time, blood loss, and recovery time. Endoscopy offers the additional advantage to the surgeon of placing the surgeon's eye not 50 cm away through the lens of loupes or a microscope, but right at the spine pathology in high definition. Uniportal approach involves a single incision through which the endoscope and instruments are passed. Biportal approach involves two incisions, one for the endoscope and one for the instruments. In what follows we review the indications and efficacy of these procedures with case examples.

{"title":"Biportal Versus Uniportal Lumbar Decompression-Indications and Efficacy: A Review With Case Examples.","authors":"Felicia W Sun, Ki-Eun Chang, Jian Shen, Albert E Telfeian","doi":"10.1227/neu.0000000000003339","DOIUrl":"https://doi.org/10.1227/neu.0000000000003339","url":null,"abstract":"<p><p>Minimally invasive lumbar decompression surgery offers many advantages including reduced patient morbidity and quicker return to normal life. Endoscopic lumbar spine surgery, sometimes termed \"ultra\" minimally invasive, further pushes the envelope on reducing operative time, blood loss, and recovery time. Endoscopy offers the additional advantage to the surgeon of placing the surgeon's eye not 50 cm away through the lens of loupes or a microscope, but right at the spine pathology in high definition. Uniportal approach involves a single incision through which the endoscope and instruments are passed. Biportal approach involves two incisions, one for the endoscope and one for the instruments. In what follows we review the indications and efficacy of these procedures with case examples.</p>","PeriodicalId":19276,"journal":{"name":"Neurosurgery","volume":"96 3S","pages":"S63-S68"},"PeriodicalIF":3.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143414849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Iodine-123-Iomazenil Single-Photon Emission Computed Tomography Revealed Recovery of Neuronal Viability in Association With Improvement of Cognitive Dysfunction After Revascularization in Moyamoya Disease. 碘-123-碘马硒单光子发射计算机断层扫描显示神经元活力的恢复与莫亚莫亚病血管重建后认知功能障碍的改善有关。
IF 3.9 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-03-01 Epub Date: 2024-07-23 DOI: 10.1227/neu.0000000000003127
Hideyuki Yoshioka, Takuma Wakai, Koji Hashimoto, Toru Tateoka, Norito Fukuda, Ryo Horiuchi, Takako Umeda, Hiroshi Onishi, Hiroyuki Kinouchi

Background and objectives: Recent studies indicate that 123 I-iomazenil ( 123 I-IMZ) single-photon emission computed tomography (SPECT) can demonstrate neuronal viability. Although cognitive dysfunction has been recognized as an important issue in adult patients with moyamoya disease (MMD), no standard neuroradiological methods to define such conditions have been established. We examined the relationship between cognitive function and 123 I-IMZ SPECT before and after revascularization in patients with MMD.

Methods: The study participants were 16 adult patients with MMD whose cerebrovascular reactivities were decreased only on the surgical sides of combined revascularization. Cognitive function was examined using the Mini-Mental State Examination (MMSE; cutoff: 27) and the Frontal Assessment Battery (FAB; cutoff: 16) before and at 3 to 6 months after surgery. 123 I-iodoamphetamine ( 123 I-IMP) SPECT with acetazolamide challenge and 123 I-IMZ SPECT were performed concurrently while evaluating cognitive function. The radioreactivities of 123 I-IMZ SPECT in regions with decreased cerebrovascular reactivities on 123 I-IMP SPECT were investigated using affected-to-contralateral side asymmetry ratio (IMZ-ACR).

Results: Twelve patients showed normal cognitive function (MMSE: 29.8 ± 0.4, FAB: 18 ± 0) before surgery. No evident laterality of 123 I-IMZ uptake was seen (IMZ-ACR: 0.98 ± 0.04). Neither cognitive function nor 123 I-IMZ SPECT worsened after surgery (MMSE: 29.8 ± 0.3, FAB: 18 ± 0, IMZ-ACR: 1.00 ± 0.04). By contrast, 4 patients presented cognitive dysfunction (MMSE: 24.3 ± 3.9, FAB: 14.8 ± 2.7) before revascularization. Preoperative imaging of these patients showed decreased 123 I-IMZ uptake, and their IMZ-ACRs (0.83 ± 0.08) were significantly lower than those of the normal group. After revascularization, cognitive functions and 123 I-IMZ uptake tended to ameliorate (MMSE: 27.5 ± 1.7, FAB: 16.3 ± 2.2, IMZ-ACR: 0.94 ± 0.09).

Conclusion: Preoperative cognitive function was associated with 123 I-IMZ uptake in adult patients with MMD. After revascularization, cognitive function could be recovered in the viable areas of the brain, which is consistent with 123 I-IMZ SPECT findings.

背景和目的:最近的研究表明,123I-异马西尼(123I-IMZ)单光子发射计算机断层扫描(SPECT)可以显示神经元的活力。虽然认知功能障碍已被认为是成年莫亚莫亚氏病(MMD)患者的一个重要问题,但目前还没有确定此类病症的标准神经放射学方法。我们研究了MMD患者血管重建前后认知功能与123I-IMZ SPECT之间的关系:研究对象为 16 名成年多发性硬化症患者,他们的脑血管反应性仅在联合血管再通手术侧有所降低。在手术前和手术后3至6个月,使用迷你精神状态检查(MMSE;分界点:27)和额叶评估电池(FAB;分界点:16)检查认知功能。在评估认知功能时,还同时进行了123I-碘苯丙胺(123I-IMP)SPECT与乙酰唑胺挑战和123I-IMZ SPECT。使用患侧与对侧的不对称比(IMZ-ACR)对123I-IMZ SPECT在123I-IMP SPECT上脑血管反应性降低的区域的放射性反应性进行了调查:12名患者术前认知功能正常(MMSE:29.8 ± 0.4,FAB:18 ± 0)。123I-IMZ摄取无明显偏侧(IMZ-ACR:0.98 ± 0.04)。术后认知功能和 123I-IMZ SPECT 均未恶化(MMSE:29.8 ± 0.3,FAB:18 ± 0,IMZ-ACR:1.00 ± 0.04)。相比之下,4 名患者在血管再通术前出现认知功能障碍(MMSE:24.3 ± 3.9,FAB:14.8 ± 2.7)。这些患者的术前成像显示123I-IMZ摄取减少,其IMZ-ACR(0.83 ± 0.08)明显低于正常组。血管再通后,认知功能和123I-IMZ摄取量趋于改善(MMSE:27.5 ± 1.7,FAB:16.3 ± 2.2,IMZ-ACR:0.94 ± 0.09):成年多发性硬化症患者术前的认知功能与123I-IMZ摄取量有关。结论:成年多发性硬化症患者术前的认知功能与123I-IMZ摄取量有关,血管再通后,脑部有活力区域的认知功能可以恢复,这与123I-IMZ SPECT的结果一致。
{"title":"Iodine-123-Iomazenil Single-Photon Emission Computed Tomography Revealed Recovery of Neuronal Viability in Association With Improvement of Cognitive Dysfunction After Revascularization in Moyamoya Disease.","authors":"Hideyuki Yoshioka, Takuma Wakai, Koji Hashimoto, Toru Tateoka, Norito Fukuda, Ryo Horiuchi, Takako Umeda, Hiroshi Onishi, Hiroyuki Kinouchi","doi":"10.1227/neu.0000000000003127","DOIUrl":"10.1227/neu.0000000000003127","url":null,"abstract":"<p><strong>Background and objectives: </strong>Recent studies indicate that 123 I-iomazenil ( 123 I-IMZ) single-photon emission computed tomography (SPECT) can demonstrate neuronal viability. Although cognitive dysfunction has been recognized as an important issue in adult patients with moyamoya disease (MMD), no standard neuroradiological methods to define such conditions have been established. We examined the relationship between cognitive function and 123 I-IMZ SPECT before and after revascularization in patients with MMD.</p><p><strong>Methods: </strong>The study participants were 16 adult patients with MMD whose cerebrovascular reactivities were decreased only on the surgical sides of combined revascularization. Cognitive function was examined using the Mini-Mental State Examination (MMSE; cutoff: 27) and the Frontal Assessment Battery (FAB; cutoff: 16) before and at 3 to 6 months after surgery. 123 I-iodoamphetamine ( 123 I-IMP) SPECT with acetazolamide challenge and 123 I-IMZ SPECT were performed concurrently while evaluating cognitive function. The radioreactivities of 123 I-IMZ SPECT in regions with decreased cerebrovascular reactivities on 123 I-IMP SPECT were investigated using affected-to-contralateral side asymmetry ratio (IMZ-ACR).</p><p><strong>Results: </strong>Twelve patients showed normal cognitive function (MMSE: 29.8 ± 0.4, FAB: 18 ± 0) before surgery. No evident laterality of 123 I-IMZ uptake was seen (IMZ-ACR: 0.98 ± 0.04). Neither cognitive function nor 123 I-IMZ SPECT worsened after surgery (MMSE: 29.8 ± 0.3, FAB: 18 ± 0, IMZ-ACR: 1.00 ± 0.04). By contrast, 4 patients presented cognitive dysfunction (MMSE: 24.3 ± 3.9, FAB: 14.8 ± 2.7) before revascularization. Preoperative imaging of these patients showed decreased 123 I-IMZ uptake, and their IMZ-ACRs (0.83 ± 0.08) were significantly lower than those of the normal group. After revascularization, cognitive functions and 123 I-IMZ uptake tended to ameliorate (MMSE: 27.5 ± 1.7, FAB: 16.3 ± 2.2, IMZ-ACR: 0.94 ± 0.09).</p><p><strong>Conclusion: </strong>Preoperative cognitive function was associated with 123 I-IMZ uptake in adult patients with MMD. After revascularization, cognitive function could be recovered in the viable areas of the brain, which is consistent with 123 I-IMZ SPECT findings.</p>","PeriodicalId":19276,"journal":{"name":"Neurosurgery","volume":" ","pages":"577-584"},"PeriodicalIF":3.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141748706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Reply: What Are We Transfusing? Evaluating the Quality and Clinical Utility of Intraoperatively Salvaged Red Blood Cells in Spinal Deformity Surgery: A Nonrandomized Controlled Trial. 回答:我们在输什么?评估脊柱畸形手术中术中回收红细胞的质量和临床应用:一项非随机对照试验。
IF 3.9 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-03-01 Epub Date: 2025-01-08 DOI: 10.1227/neu.0000000000003323
David B Kurland, Darryl Lau
{"title":"In Reply: What Are We Transfusing? Evaluating the Quality and Clinical Utility of Intraoperatively Salvaged Red Blood Cells in Spinal Deformity Surgery: A Nonrandomized Controlled Trial.","authors":"David B Kurland, Darryl Lau","doi":"10.1227/neu.0000000000003323","DOIUrl":"10.1227/neu.0000000000003323","url":null,"abstract":"","PeriodicalId":19276,"journal":{"name":"Neurosurgery","volume":" ","pages":"e70-e71"},"PeriodicalIF":3.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142952161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Neurosurgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1